Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep 1;85(9):1383–1386. doi: 10.1054/bjoc.2001.2068

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours

S Jefferies 1, S M Edwards 1, R A Hamoudi 1, R A'Hern 2, W Foulkes 3, D Goldgar 4; M. P. T. Collaborators5,6,7,8,9,1, R Eeles 1,2
PMCID: PMC2375247  PMID: 11720478

Abstract

There is increasing evidence that predisposition to some cancers has a genetic component. There is a high incidence of loss of heterozygosity on chromosome 9, in the region of tumour suppressor gene CDKN2A (also known as p16), in sporadic squamous cell cancer of the head and neck (SCCHN). To investigate the possibility that CDKN2A may be involved in the inherited susceptibility to SCCHN, the 3 coding exons of CDKN2A were sequenced in 40 patients who had developed a second primary cancer after an index squamous cell cancer of the head and neck. No mutations were found and we conclude that CDKN2A mutations do not play a major role in cancer susceptibility in this group. © 2001 Cancer Research Campaign

Keywords: squamous cell cancer of the head and neck, CDKN2A (p16) gene, mutation

Full Text

The Full Text of this article is available as a PDF (58.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedi G. C., Westra W. H., Gabrielson E., Koch W., Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res. 1996 Jun 1;56(11):2484–2487. [PubMed] [Google Scholar]
  2. Bongers V., Braakhuis B. J., Tobi H., Lubsen H., Snow G. B. The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer. Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):595–598. [PubMed] [Google Scholar]
  3. Copper M. P., Jovanovic A., Nauta J. J., Braakhuis B. J., de Vries N., van der Waal I., Snow G. B. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1995 Feb;121(2):157–160. doi: 10.1001/archotol.1995.01890020019005. [DOI] [PubMed] [Google Scholar]
  4. Day G. L., Blot W. J. Second primary tumors in patients with oral cancer. Cancer. 1992 Jul 1;70(1):14–19. doi: 10.1002/1097-0142(19920701)70:1<14::aid-cncr2820700103>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  5. Easton D. F., Steele L., Fields P., Ormiston W., Averill D., Daly P. A., McManus R., Neuhausen S. L., Ford D., Wooster R. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet. 1997 Jul;61(1):120–128. doi: 10.1086/513891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Foulkes W. D., Brunet J. S., Kowalski L. P., Narod S. A., Franco E. L. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. Int J Cancer. 1995 Dec 11;63(6):769–773. doi: 10.1002/ijc.2910630603. [DOI] [PubMed] [Google Scholar]
  7. Foulkes W. D., Brunet J. S., Sieh W., Black M. J., Shenouda G., Narod S. A. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ. 1996 Sep 21;313(7059):716–721. doi: 10.1136/bmj.313.7059.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Franco E. L., Kowalski L. P., Kanda J. L. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. J Clin Epidemiol. 1991;44(7):615–625. doi: 10.1016/0895-4356(91)90021-z. [DOI] [PubMed] [Google Scholar]
  9. Gallo O., Sardi I., Pepe G., Franchi A., Attanasio M., Giusti B., Bocciolini C., Abbate R. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene? Int J Cancer. 1999 Jul 19;82(2):180–186. doi: 10.1002/(sici)1097-0215(19990719)82:2<180::aid-ijc5>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  10. Hamel N., Manning A., Black M. J., Tonin P. N., Foulkes W. D. An absence of founder BRCA2 mutations in individuals with squamous cell carcinoma of the head and neck. Int J Cancer. 1999 Dec 10;83(6):803–804. doi: 10.1002/(sici)1097-0215(19991210)83:6<803::aid-ijc17>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  11. Harland M., Holland E. A., Ghiorzo P., Mantelli M., Bianchi-Scarrà G., Goldstein A. M., Tucker M. A., Ponder B. A., Mann G. J., Bishop D. T. Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer. 2000 May;28(1):45–57. [PubMed] [Google Scholar]
  12. Harland M., Meloni R., Gruis N., Pinney E., Brookes S., Spurr N. K., Frischauf A. M., Bataille V., Peters G., Cuzick J. Germline mutations of the CDKN2 gene in UK melanoma families. Hum Mol Genet. 1997 Nov;6(12):2061–2067. doi: 10.1093/hmg/6.12.2061. [DOI] [PubMed] [Google Scholar]
  13. Hong W. K., Lippman S. M., Itri L. M., Karp D. D., Lee J. S., Byers R. M., Schantz S. P., Kramer A. M., Lotan R., Peters L. J. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990 Sep 20;323(12):795–801. doi: 10.1056/NEJM199009203231205. [DOI] [PubMed] [Google Scholar]
  14. Hussussian C. J., Struewing J. P., Goldstein A. M., Higgins P. A., Ally D. S., Sheahan M. D., Clark W. H., Jr, Tucker M. A., Dracopoli N. C. Germline p16 mutations in familial melanoma. Nat Genet. 1994 Sep;8(1):15–21. doi: 10.1038/ng0994-15. [DOI] [PubMed] [Google Scholar]
  15. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S., 3rd, Johnson B. E., Skolnick M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994 Apr 15;264(5157):436–440. doi: 10.1126/science.8153634. [DOI] [PubMed] [Google Scholar]
  16. Kunkel L. M., Smith K. D., Boyer S. H., Borgaonkar D. S., Wachtel S. S., Miller O. J., Breg W. R., Jones H. W., Jr, Rary J. M. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1245–1249. doi: 10.1073/pnas.74.3.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Leong P. P., Rezai B., Koch W. M., Reed A., Eisele D., Lee D. J., Sidransky D., Jen J., Westra W. H. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst. 1998 Jul 1;90(13):972–977. doi: 10.1093/jnci/90.13.972. [DOI] [PubMed] [Google Scholar]
  18. Liu L., Dilworth D., Gao L., Monzon J., Summers A., Lassam N., Hogg D. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet. 1999 Jan;21(1):128–132. doi: 10.1038/5082. [DOI] [PubMed] [Google Scholar]
  19. Lynch H. T., Fusaro R. M., Pester J., Oosterhuis J. A., Went L. N., Rumke P., Neering H., Lynch J. F. Tumour spectrum in the FAMMM syndrome. Br J Cancer. 1981 Oct;44(4):553–560. doi: 10.1038/bjc.1981.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Macfarlane G. J., Boyle P., Evstifeeva T. V., Robertson C., Scully C. Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control. 1994 May;5(3):259–265. doi: 10.1007/BF01830246. [DOI] [PubMed] [Google Scholar]
  21. Maier H., Dietz A., Gewelke U., Heller W. D. Berufliche Exposition gegenüber Schadstoffen und Krebsrisiko im Bereich von Mundhöhle, Oropharynx, Hypopharynx und Larynx. Eine Fall-Kontrollstudie. Laryngorhinootologie. 1991 Feb;70(2):93–98. doi: 10.1055/s-2007-997996. [DOI] [PubMed] [Google Scholar]
  22. Maier H., Dietz A., Gewelke U., Heller W. D., Weidauer H. Tobacco and alcohol and the risk of head and neck cancer. Clin Investig. 1992 Mar-Apr;70(3-4):320–327. doi: 10.1007/BF00184668. [DOI] [PubMed] [Google Scholar]
  23. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Miracca E. C., Kowalski L. P., Nagai M. A. High prevalence of p16 genetic alterations in head and neck tumours. Br J Cancer. 1999 Oct;81(4):677–683. doi: 10.1038/sj.bjc.6690747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Morita M., Kuwano H., Nakashima T., Taketomi A., Baba H., Saito T., Tomoda H., Egashira A., Kawaguchi H., Kitamura K. Family aggregation of carcinoma of the hypopharynx and cervical esophagus: special reference to multiplicity of cancer in upper aerodigestive tract. Int J Cancer. 1998 May 18;76(4):468–471. doi: 10.1002/(sici)1097-0215(19980518)76:4<468::aid-ijc4>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  26. Muscat J. E., Wynder E. L. Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer. 1992 May 1;69(9):2244–2251. doi: 10.1002/1097-0142(19920501)69:9<2244::aid-cncr2820690906>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  27. Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993 Jun 19;54(4):594–606. doi: 10.1002/ijc.2910540413. [DOI] [PubMed] [Google Scholar]
  28. Reed A. L., Califano J., Cairns P., Westra W. H., Jones R. M., Koch W., Ahrendt S., Eby Y., Sewell D., Nawroz H. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996 Aug 15;56(16):3630–3633. [PubMed] [Google Scholar]
  29. Scholes A. G., Woolgar J. A., Boyle M. A., Brown J. S., Vaughan E. D., Hart C. A., Jones A. S., Field J. K. Synchronous oral carcinomas: independent or common clonal origin? Cancer Res. 1998 May 1;58(9):2003–2006. [PubMed] [Google Scholar]
  30. Serrano M., Hannon G. J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993 Dec 16;366(6456):704–707. doi: 10.1038/366704a0. [DOI] [PubMed] [Google Scholar]
  31. Sun S., Pollock P. M., Liu L., Karimi S., Jothy S., Milner B. J., Renwick A., Lassam N. J., Hayward N. K., Hogg D. CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein. Int J Cancer. 1997 Nov 14;73(4):531–536. doi: 10.1002/(sici)1097-0215(19971114)73:4<531::aid-ijc13>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  32. Tonin P. N., Mes-Masson A. M., Futreal P. A., Morgan K., Mahon M., Foulkes W. D., Cole D. E., Provencher D., Ghadirian P., Narod S. A. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet. 1998 Nov;63(5):1341–1351. doi: 10.1086/302099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Trizna Z., Schantz S. P. Hereditary and environmental factors associated with risk and progression of head and neck cancer. Otolaryngol Clin North Am. 1992 Oct;25(5):1089–1103. [PubMed] [Google Scholar]
  34. Vokes E. E., Weichselbaum R. R., Lippman S. M., Hong W. K. Head and neck cancer. N Engl J Med. 1993 Jan 21;328(3):184–194. doi: 10.1056/NEJM199301213280306. [DOI] [PubMed] [Google Scholar]
  35. Wang Q., Lasset C., Sobol H., Ozturk M. Evidence of a hereditary p53 syndrome in cancer-prone families. Int J Cancer. 1996 Feb 8;65(4):554–557. [PubMed] [Google Scholar]
  36. Whelan A. J., Bartsch D., Goodfellow P. J. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med. 1995 Oct 12;333(15):975–977. doi: 10.1056/NEJM199510123331505. [DOI] [PubMed] [Google Scholar]
  37. Worsham M. J., Wolman S. R., Carey T. E., Zarbo R. J., Benninger M. S., Van Dyke D. L. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol. 1995 Mar;26(3):251–261. doi: 10.1016/0046-8177(95)90054-3. [DOI] [PubMed] [Google Scholar]
  38. Yarbrough W. G., Aprelikova O., Pei H., Olshan A. F., Liu E. T. Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst. 1996 Oct 16;88(20):1489–1491. doi: 10.1093/jnci/88.20.1489. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES